11 ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................... CSR contributions 0.3 $ million At a glance Revenue $115.9million Fixed assets $103.4million Profit after tax (PAT) $8.3million We work with innovator pharma and biotech companies to accelerate the discovery, development, and manufacture of complex small molecules for a healthier tomorrow. Our vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey. Our work is built on the firm bedrock of partnership. We are committed to being flexible, responsive, and innovative in addressing the evolving needs of our customers and the environment. Together we better the lives for patients around the world. .
RkJQdWJsaXNoZXIy MTIwMDc4NQ==